日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correlation between quantitative DCE-MRI and pathologic complete response in patients with invasive ductal carcinoma undergoing neoadjuvant systemic therapy

定量动态增强磁共振成像与接受新辅助全身治疗的浸润性导管癌患者的病理完全缓解之间的相关性

Wang, Xingrui; Xiao, Xuehong; Yang, Ang; Zeng, Shuyan; Chen, Wenxi; Chen, Yi; Cui, Shien; Huang, Zhihua; Zeng, Yumei; Huang, Xiaoxing

Efficacy and safety of eribulin plus gemcitabine as second-line treatment for recurrent HER2-negative breast cancer: a phase II, single-arm, open-label trial

艾立布林联合吉西他滨作为复发性HER2阴性乳腺癌二线治疗的疗效和安全性:一项II期、单臂、开放标签试验

Xu, Xiaolu; Zhong, Jincai; Lin, Hong; Wang, Hong; Ye, Jinhui; Du, Caiwen; Wang, Zhihui; Zou, Guorong; Ouyang, Jie; Yu, Gengsheng; Wang, Yongxia; Li, Luzhen; Xu, Fei; Cui, Shien; Xiao, Mei; Peng, Peijian

TBL2 Promotes Tumorigenesis via PRMT5/WDR77-Mediated AKT Activation in Breast Cancer.

TBL2 通过 PRMT5/WDR77 介导的 AKT 激活促进乳腺癌的肿瘤发生

Lu Xiuqing, Zhang Chao, Zhu Lewei, Wang Sifen, Zeng Lijun, Zhong Wenjing, Wu Xuxia, Yuan Qi, Tang Hailin, Cui Shien, Tan Yeru, Li Yuehua, Wei Weidong

RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer

肿瘤微环境细胞的RNA甲基化模式调控三阴性乳腺癌患者的预后和免疫治疗反应

Li, Tingjun; Huang, Yiqin; Cui, Shien; Hong, Zhipeng; Zhang, Xinhai; Li, Zhihao; Chen, Kunqi; Chen, Debo

Correction to: NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth

更正:NAP1L1 与肝癌衍生生长因子相互作用,募集 c-Jun 诱导乳腺癌生长

Liu, Shu; Zhang, Yewei; Cui, Shien; Song, Dajiang; Li, Bo; Chen, Qian; Yao, Guangyu; Gong, Bin